Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway

Area of Science:

• * Molecular Biology
• * Cancer Research
• * Immunology

Background:

• * Curcumin, a turmeric extract, exhibits anti-cancer properties, but its precise mechanisms vary across cancer types.
• * Leukemic cell lines U937 and K562 show differential responses to curcumin treatment.
• * Understanding the molecular basis of curcumin's efficacy is crucial for therapeutic development.

Purpose of the Study:

• * To elucidate the molecular mechanisms underlying curcumin-induced apoptosis in U937 human leukemic cells.
• * To investigate the role of interferon-induced genes, specifically IFIT2, in curcumin's anti-leukemic effects.
• * To explore the potential of targeting IFIT2 for enhancing curcumin's anti-cancer activity.

Main Methods:

• * Gene expression profiling (chip array) and Western blot analysis to assess gene and protein expression.
• * RNA interference (shRNA) to inhibit IFIT2 expression in U937 cells.
• * Lentiviral transduction and IFNγ treatment to overexpress IFIT2 in K562 cells.

Main Results:

• * Curcumin induced G2/M cell cycle arrest and apoptosis in U937 cells, evidenced by changes in caspase-3, PARP, and BCL-2 levels.
• * Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2) expression was significantly upregulated by curcumin in U937 cells.
• * Inhibition of IFIT2 expression reversed curcumin-induced apoptosis, while IFIT2 overexpression enhanced curcumin's anti-cancer effects in K562 cells.

Conclusions:

• * Curcumin induces leukemic cell apoptosis through an IFIT2-dependent signaling pathway.
• * IFIT2 plays a critical role in mediating the anti-leukemic effects of curcumin.
• * This study provides a novel mechanism for curcumin's antitumor activity and suggests potential combination therapy with interferons.